Unknown OBSERVATIONAL NCT02253485

Efficacy of Antiviral Therapy in Pregnancy in Preventing Vertical Transmission of HBV in Mothers With a High Viral Load

Case-control Study of Antiviral Therapy During Entire and the Third Trimester of Pregnancy in Preventing MTCT of HBV in Mothers With High Serum HBV DNA Load

Sponsor: Beijing Ditan Hospital

Conditions Immune Globulin, Prophylaxis, Telbuvidine, Vaccine

Interventions telbivudine

Updated 6 times since 2017 Last updated: Sep 29, 2014 Started: Aug 31, 2012 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02253485, this observational or N/A phase trial focuses on Immune Globulin, Prophylaxis, Telbuvidine, Vaccine and remains ongoing. Sponsored by Beijing Ditan Hospital, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Apr 2018 — Jan 2021 [monthly]

Unknown Status

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Unknown Status NA

Status: Enrolling By Invitation → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation NA

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Ditan Hospital

Data source: Beijing Ditan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.